IGM Biosciences, Inc.

DB:1K0 Stock Report

Market Cap: €357.9m

IGM Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:1K0 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Dec 24Sell€12,163Mary HarlerIndividual1,708€7.12
16 Dec 24Sell€12,163Misbah TahirIndividual1,708€7.12
16 Dec 24Sell€7,570Lisa DeckerIndividual1,063€7.12
16 Dec 24Sell€3,838Steven WeberIndividual539€7.12
13 Sep 24Sell€15,475Mary HarlerIndividual1,487€10.41
13 Sep 24Sell€9,626Lisa DeckerIndividual925€10.41
13 Sep 24Sell€41,065Fred SchwarzerIndividual3,946€10.41
13 Sep 24Sell€15,475Chris TakimotoIndividual1,487€10.41
13 Sep 24Sell€15,475Bruce KeytIndividual1,487€10.41
13 Sep 24Sell€15,475Misbah TahirIndividual1,487€10.41
13 Sep 24Sell€4,881Steven WeberIndividual469€10.41
14 Jun 24Sell€11,119Mary HarlerIndividual1,570€7.08
14 Jun 24Sell€11,119Chris TakimotoIndividual1,570€7.08
14 Jun 24Sell€3,506Steven WeberIndividual495€7.08
14 Jun 24Sell€6,919Lisa DeckerIndividual977€7.08
14 Jun 24Sell€7,833Bruce KeytIndividual1,106€7.08
14 Jun 24Sell€29,490Fred SchwarzerIndividual4,164€7.08
14 Jun 24Sell€11,119Misbah TahirIndividual1,570€7.08
28 Mar 24Buy€3,171,391Baker Bros. Advisors LPCompany395,317€8.91
14 Mar 24Sell€31,036Lisa DeckerIndividual3,376€9.34
14 Mar 24Sell€36,267Bruce KeytIndividual3,945€9.34
14 Mar 24Sell€82,251Fred SchwarzerIndividual8,947€9.34
14 Mar 24Sell€50,011Misbah TahirIndividual5,440€9.34
14 Mar 24Sell€49,864Chris TakimotoIndividual5,424€9.34
14 Mar 24Sell€9,129Steven WeberIndividual993€9.34

Insider Trading Volume

Insider Buying: 1K0 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1K0?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,492,5152.51%
General Public3,071,6245.17%
VC/PE Firms3,330,4225.6%
Institutions11,124,72718.7%
Private Companies15,444,85926%
Hedge Funds25,000,03442%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 92.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26%
Topsøe Holding A/S
15,444,859€93.0m0%no data
25%
Baker Bros. Advisors LP
14,837,522€89.3m0.16%0.95%
17.1%
Redmile Group, LLC
10,162,512€61.2m-1.06%3.78%
6.75%
T. Rowe Price Group, Inc.
4,014,259€24.2m-1.49%no data
5.6%
Artal Group S.A.
3,330,422€20.0m0%0.64%
2.09%
Goldman Sachs Group, Investment Banking and Securities Investments
1,245,460€7.5m-5.72%no data
1.51%
BlackRock, Inc.
899,921€5.4m1.91%no data
1.5%
The Vanguard Group, Inc.
890,200€5.4m1.32%no data
1.38%
FMR LLC
819,286€4.9m0.05%no data
0.79%
State Street Global Advisors, Inc.
469,790€2.8m2.66%no data
0.69%
M. Behrens
409,593€2.5m0.76%no data
0.67%
Geode Capital Management, LLC
395,799€2.4m7.65%no data
0.58%
Mary Harler
347,032€2.1m112%no data
0.42%
Fred Schwarzer
250,228€1.5m1.51%no data
0.37%
Invesco Capital Management LLC
219,409€1.3m6,540%no data
0.32%
Northern Trust Global Investments
191,673€1.2m42.3%no data
0.31%
Rhenman & Partners Asset Management AB
185,459€1.1m-4.89%0.09%
0.28%
TD Asset Management, Inc.
164,472€989.8k0%no data
0.25%
Charles Schwab Investment Management, Inc.
148,402€893.2k12.2%no data
0.22%
Millennium Management LLC
132,342€796.5k-66.2%no data
0.18%
Bruce Keyt
109,896€661.4k1.29%no data
0.17%
Bruce & Co Inc
100,000€601.8k0%0.2%
0.17%
Wellington Management Group LLP
98,339€591.9k42.6%no data
0.16%
D. E. Shaw & Co., L.P.
97,716€588.1k-25.4%no data
0.15%
Jakob Topsoe
90,056€542.0k1.96%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 06:35
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IGM Biosciences, Inc. is covered by 15 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Etzer DaroutBMO Capital Markets Equity Research
Geoffrey MeachamBofA Global Research
Charlie YangBofA Global Research